Invesco V.I. Health Care Fund
Data updated: 2026-08-25
C000000432 — Invesco V.I. Health Care Fund. United States Large Cap Blend / Core Health Care Equity. Holdings, fees, performance and SEC filings.
C000000432 Fund Overview
Invesco V.I. Health Care Fund is a US mutual fund managed by AIM Variable Insurance Funds (Invesco Variable Insurance Funds), categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: AIM Variable Insurance Funds (Invesco Variable Insurance Funds)
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $160.63M
- 1-year return: 16.0%
- SEC CIK: 0000896435
- SEC series ID: S000000193
- Share class ID: C000000432
C000000432 Investment Objective and Strategy
Invesco V.I. Health Care Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by AIM Variable Insurance Funds (Invesco Variable Insurance Funds).
Investment objective
The Funds investment objective is long-term growth of capital.
Principal investment strategy
The Fund invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of issuers engaged primarily in health care-related industries, and in derivatives and other instruments that have economic characteristics similar to such securities. The Fund will concentrate its investments in the securities of domestic and foreign issuers in the health care industry. The Fund uses various criteria to determine whether an issuer is engaged in health care-related industries, including whether (1) it derives 50% or more of its gross income or its net sales from activities in the health care industry; (2) it devotes 50% or more of its assets to producing revenues from the health care industry; or (3) based on other available information, the Funds portfolio managers determine that its primary business is within the health care industry.
Such other available information may include industry classifications from any one or more third-party providers, such as those using the Global Industry Classification Standard (GICS ), the North American Industry Classification System (NAICS), or the Bloomberg Industry Classification System (BICS). Issuers engaged in health care-related industries include those that design, provide, distribute, manufacture, or sell products or services used for or in connection with health care or medicine (such as pharmaceutical issuers, biotechnology research firms, companies that make or sell medical products, and companies that own or operate health care facilities and systems). The Fund invests primarily in equity securities, including common and preferred stock, and depositary receipts. The Fund may invest in the securities of issuers of all capitalization sizes and may invest a significant amount of its net assets in the securities of small- and mid-capitalization issuers.
The Fund may invest in securities of foreign issuers including up to 20% of its net assets in securities of issuers located in emerging markets countries, i.e., those that are generally in the early stages of their industrial cycles. The Fund can invest in derivative instruments, including forward foreign currency contracts. The Fund can use forward foreign currency contracts to seek to hedge against adverse movements in the foreign currencies in which portfolio securities are denominated. In selecting securities for the Fund, the portfolio managers use a research-oriented bottom-up investment approach, focusing on issuer fundamentals and the strength of an individual issuer before considering the impact of overall economic, market, sector or industry trends. This approach includes analysis of a company's financial statements and management structure and consideration of the company's operations, product development, and its industry position.
The portfolio managers currently focus on companies that the portfolio managers believe are characterized by industry leadership, market share growth, high caliber management teams, sustainable competitive advantages, and strong growth themes or new innovative products or services. The portfolio managers monitor individual issuers for changes in the factors above, which may trigger a decision to sell a security, but does not require a decision to do so. The factors considered by the portfolio managers may vary in particular cases and may change over time.
C000000432 Holdings
Top 10 holdings of Invesco V.I. Health Care Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly and Co. | 10.84% |
| Invesco Private Prime Fund | 7.90% |
| Johnson & Johnson | 6.27% |
| UnitedHealth Group Inc. | 6.08% |
| Merck & Co., Inc. | 4.20% |
| argenx SE | 3.98% |
| AbbVie Inc. | 3.98% |
| Gilead Sciences, Inc. | 3.45% |
| Invesco Private Government Fund | 3.04% |
| AstraZeneca PLC | 2.93% |
C000000432 Portfolio Allocation
Asset-class allocation of Invesco V.I. Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 97.6% |
| Cash & Equivalents | 13.4% |
C000000432 Performance
Total returns for C000000432 (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 3.7% |
| 1 year | 16.0% |
| 3 years (annualised) | 7.7% |
| 5 years (annualised) | 3.5% |
C000000432 Risk Information
Risk metrics for C000000432, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.0%
C000000432 Costs and Fees
C000000432 costs about $99 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.99%
- Gross expense ratio: 0.99%
- Portfolio turnover: 52%
- Brokerage commissions: 3.37 bps of average net assets (SEC N-CEN)
C000000432 Cashflows
Over the 12 months to 2026-06, Invesco V.I. Health Care Fund had net outflows of $14.61M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | −$999.76K |
| 2026-05 | −$589.23K |
| 2026-04 | −$1.59M |
| 2026-03 | −$1.96M |
| 2026-02 | −$5.40M |
| 2026-01 | −$2.53M |
C000000432 Debt Constituents
No individual debt constituents are reported in Invesco V.I. Health Care Fund's latest SEC N-PORT filing.
C000000432 Prospectus and SEC Filings
Official Invesco V.I. Health Care Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-29
- Prospectus (485BPOS) — filed 2025-04-29
- Prospectus (485BPOS) — filed 2024-04-25
- Portfolio holdings (N-PORT) — filed 2026-08-25
- Portfolio holdings (N-PORT) — filed 2026-05-28
- Portfolio holdings (N-PORT) — filed 2026-02-27
- Annual census (N-CEN) — filed 2026-03-16
- Annual census (N-CEN) — filed 2025-03-17
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.